Dual-Drug Conjugated Glyco-Nanoassemblies for Tumor-Triggered Targeting and Synergistic Cancer Therapy

被引:8
作者
Katmerlikaya, Tugba Gencoglu [1 ]
Dag, Aydan [5 ]
Ozgen, Pinar Sinem Omurtag [2 ,3 ]
Ersen, Busra Cetin [4 ]
机构
[1] Bezmialem Vakif Univ, Inst Hlth Sci, Dept Biotechnol, TR-34093 Istanbul, Turkey
[2] Istanbul Medipol Univ, Sch Pharm, Dept Analyt Chem, TR-34810 Istanbul, Turkey
[3] Marmara Univ, Fac Pharm, Dept Basic Pharm Sci, TR-34854 Istanbul, Turkey
[4] Ankara Haci Bayram Veli Univ, Inst Grad Studies, Dept Chem, TR-06900 Ankara, Turkey
[5] Bezmialem Vakif Univ, Fac Pharm & Pharmaceut Applicat & Res Ctr, Dept Pharmaceut Chem, TR-34093 Istanbul, Turkey
关键词
glyco-nanoassemblies; gemcitabine; cisPt; cellular uptake; synergistic chemotherapy; GEMCITABINE; DELIVERY;
D O I
10.1021/acsabm.2c00749
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Drug-conjugated nanoassemblies potentiate the efficiency of anticancer drugs through the advantages of high drug-loading capacity and passive/active targeting ability in cancer therapy. This study describes the synthesis of gemcitabine (Gem) and cisplatin (cisPt) dual-drug-functionalized glyco-nanoassemblies (GNs) for anticancer drug delivery systems. It also investigates the pH-triggered drug delivery of the conventional anticancer drug cisPt. A Gem-functionalized well-defined glycoblock copolymer backbone (P(iprFruMA-b-MAc)-Gem), which consists of fructose and methacrylic acid segments, was synthesized via a reversible addition-fragmentation chain transfer (RAFT) polymerization method. Following the hydrolysis of the protecting groups on the backbone copolymer, cisPt functionalization of P(FruMA-b-MAc)-Gem in aqueous media was carried out during the transformation of glycoblock polymers into self-assembled spherical glyco-nanoassemblies (GN3). Monodrug-functionalized glyco-nanoassemblies were also prepared either with Gem (GN1) or cisPt (GN2) to compare the synergetic effect of dual-drug conjugated glyco-nanoassemblies (GN3). The sizes of glyco-nanoassemblies GN1, GN2, and GN3 were found as 5.76 +/- 0.64, 59.80 +/- 0.13, and 53.80 +/- 3.90 nm and dispersity (D) values as 0.476, 0.292, and 0.311 by dynamic light scattering (DLS) measurement, respectively. The in vitro studies revealed that the drug-free glyco-nanoassemblies are biocompatible at concentrations higher than 296 mu g/mL. The drug-conjugated glyco-nanoassemblies (GN1 and GN2) exhibited in vitro cytotoxicity against human breast cancer cell lines of MDA-MB-231 comparable to free Gem and cisPt, illustrating an efficient drug release into the tumor environment. Additionally, GNs exhibited higher selectivity and preferential cellular internalization in MDA-MB-231 when compared to healthy cell lines of CCD-1079Sk. These dual-drug conjugated GNs can effectively enhance the killing of cancer cells and increase synergistic chemotherapy.
引用
收藏
页码:5356 / 5364
页数:9
相关论文
共 50 条
  • [21] Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells
    Zhu, Ying
    Wang, Anni
    Zhang, Shuya
    Kim, Jisu
    Xia, Jiaxuan
    Zhang, Fengxue
    Wang, Dan
    Wang, Qi
    Wang, Jianxin
    JOURNAL OF ADVANCED RESEARCH, 2023, 49 : 159 - 173
  • [22] 808 nm near-infrared light controlled dual-drug release and cancer therapy in vivo by upconversion mesoporous silica nanostructures
    Dai, Yunlu
    Bi, Huiting
    Deng, Xiaoran
    Li, Chunxia
    He, Fei
    Ma, Ping'an
    Yang, Piaoping
    Lin, Jun
    JOURNAL OF MATERIALS CHEMISTRY B, 2017, 5 (11) : 2086 - 2095
  • [23] Drug-drug conjugates self-assembled nanomedicines triggered photo- / immuno- therapy for synergistic cancer treatments
    Qu, Haijing
    Li, Longmeng
    Chen, Han
    Tang, Menghuan
    Cheng, Wei
    Lin, Tzu-yin
    Li, Lingyan
    Li, Bin
    Xue, Xiangdong
    JOURNAL OF CONTROLLED RELEASE, 2023, 363 : 361 - 375
  • [24] Re-engineering the inner surface of ferritin nanocage enables dual drug payloads for synergistic tumor therapy
    Wang, Zhuoran
    Zhao, Yue
    Zhang, Shuai
    Chen, Xuehui
    Sun, Guoming
    Zhang, Baoli
    Jiang, Bing
    Yang, Yili
    Yan, Xiyun
    Fan, Kelong
    THERANOSTICS, 2022, 12 (04): : 1800 - 1815
  • [25] Dual Drug Loaded, pH-Sensitive Metal-Organic Particles for Synergistic Cancer Therapy
    Wu, Shichao
    Hu, Shuo
    Yang, Xiangrui
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [26] Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy
    Yu, Qianwen
    Qiu, Yue
    Li, Jianping
    Tang, Xian
    Wang, Xuhui
    Cun, Xingli
    Xu, Shanshan
    Liu, Yayuan
    Li, Man
    Zhang, Zhirong
    He, Qin
    JOURNAL OF CONTROLLED RELEASE, 2020, 321 : 564 - 575
  • [27] NIR-laser-triggered drug release from folate decorated albumin nanoparticles for synergistic chemo-photothermal tumor therapy
    Li, Yanli
    Wang, Tianyan
    Liu, Yun
    Xu, Yi
    Sun, Zengxian
    Yang, Guangsheng
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 53
  • [28] Tumor pH-triggered "charge conversion" nanocarriers with on-demand drug release for precise cancer therapy
    Ma, Bo-Ai
    Sun, Chun-Yang
    JOURNAL OF MATERIALS CHEMISTRY B, 2020, 8 (40) : 9351 - 9361
  • [29] Targeting the "Sweet Side" of Tumor with Glycan-Binding Molecules Conjugated-Nanoparticles: Implications in Cancer Therapy and Diagnosis
    Bloise, Nora
    Okkeh, Mohammad
    Restivo, Elisa
    Della Pina, Cristina
    Visai, Livia
    NANOMATERIALS, 2021, 11 (02) : 1 - 19
  • [30] High-throughput single-cell analysis of exosome mediated dual drug delivery,in vivofate and synergistic tumor therapy
    Wang, Jinheng
    Li, Guangmeng
    Tu, Chenggong
    Chen, Xiaoming
    Yang, Bin
    Huo, Yongliang
    Li, Yi
    Chen, Ai-Zheng
    Lan, Ping
    Zhang, Yu Shrike
    Xie, Maobin
    NANOSCALE, 2020, 12 (25) : 13742 - 13756